Acalabrutinib Plus RICE Followed By Autologous Hematopoietic Cell Transplantation and/or Acalabrutinib Maintenance Therapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

被引：1
|
作者：
Bailey, Neil
Tsomo, Tenzin
Szeto, Jennie
Bensinger, William I.
Egan, Daniel
Hegerova, Livia
Mawad, Raya
Batchelder, Ami
Fesler, Joanna
Holdread, Heather
Glennie, Sonia
Hall, Judson
Ferry, Joey
Bailey, Megumi
Kane, David
Pagel, John M.
Patel, Krish
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-141074
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma
    Kewalramani, T
    Zelenetz, AD
    Nimer, SD
    Portlock, C
    Straus, D
    Noy, A
    O'Connor, O
    Filippa, DA
    Teruya-Feldstein, J
    Gencarelli, A
    Qin, J
    Waxman, A
    Yahalom, J
    Moskowitz, CH
    BLOOD, 2004, 103 (10) : 3684 - 3688
  • [42] High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma
    Aoki, T.
    Shimada, K.
    Suzuki, R.
    Izutsu, K.
    Tomita, A.
    Maeda, Y.
    Takizawa, J.
    Mitani, K.
    Igarashi, T.
    Sakai, K.
    Miyazaki, K.
    Mihara, K.
    Ohmachi, K.
    Nakamura, N.
    Takasaki, H.
    Kiyoi, H.
    Nakamura, S.
    Kinoshita, T.
    Ogura, M.
    BLOOD CANCER JOURNAL, 2015, 5 : e372 - e372
  • [43] High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma
    T Aoki
    K Shimada
    R Suzuki
    K Izutsu
    A Tomita
    Y Maeda
    J Takizawa
    K Mitani
    T Igarashi
    K Sakai
    K Miyazaki
    K Mihara
    K Ohmachi
    N Nakamura
    H Takasaki
    H Kiyoi
    S Nakamura
    T Kinoshita
    M Ogura
    Blood Cancer Journal, 2015, 5 : e372 - e372
  • [44] Cellular therapy in older adults with relapsed/refractory diffuse large B-cell lymphoma
    Esteghamat, Naseem
    Tsumura, Aaron
    Marquez-Arreguin, Gabriel
    Tuscano, Joseph
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [45] Loncastuximab tesirine: an effective therapy for relapsed or refractory diffuse large B-cell lymphoma
    Bo Xu
    European Journal of Clinical Pharmacology, 2022, 78 : 707 - 719
  • [46] R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: influence of prior autologous stem-cell transplantation on outcome
    Martin, Alejandro
    Caballero, Maria-Dolores
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (05): : 744 - 744
  • [47] Loncastuximab tesirine: an effective therapy for relapsed or refractory diffuse large B-cell lymphoma
    Xu, Bo
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (05) : 707 - 719
  • [48] Systematic Review of Therapy Used in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Galaznik, Aaron
    Bell, Jill A.
    Hoog, Meredith M.
    Stokes, Michael E.
    Steenrod, Anna W.
    Knopf, Kevin B.
    Seal, Brian
    Shou, Yaping
    BLOOD, 2016, 128 (22)
  • [49] A paradox of choice: Sequencing therapy in relapsed/refractory diffuse large B-cell lymphoma
    Brooks, Taylor R.
    Caimi, Paolo F.
    BLOOD REVIEWS, 2024, 63
  • [50] Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Is There Still a Role for Autologous Stem Cell Transplantation in the CAR T-Cell Era?
    Struessmann, Tim
    Marks, Reinhard
    Waesch, Ralph
    CANCERS, 2024, 16 (11)
12345